Avalon GloboCare Corp.
ALBT
$5.49
-$1.74-24.07%
| Weiss Ratings | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.76 | |||
| Price History | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -25.81% | |||
| 30-Day Total Return | 53.35% | |||
| 60-Day Total Return | 35.56% | |||
| 90-Day Total Return | 59.13% | |||
| Year to Date Total Return | 60.06% | |||
| 1-Year Total Return | -4.94% | |||
| 2-Year Total Return | -86.79% | |||
| 3-Year Total Return | -94.92% | |||
| 5-Year Total Return | -97.31% | |||
| 52-Week High % Change | -66.53% | |||
| 52-Week Low % Change | 242.65% | |||
| Price | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $21.60 | |||
| 52-Week Low Price | $2.11 | |||
| 52-Week Low Price (Date) | Nov 04, 2024 | |||
| 52-Week High Price (Date) | Jun 03, 2024 | |||
| Valuation | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 7.91M | |||
| Enterprise Value | 35.60M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -19.56 | |||
| Earnings Per Share Growth | 38.36% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -0.85 | |||
| Price/Book (Q) | -0.54 | |||
| Enterprise Value/Revenue (TTM) | -4.54 | |||
| Price | $5.49 | |||
| Enterprise Value/EBITDA (TTM) | -2.79 | |||
| Enterprise Value/EBIT | -2.75 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 924.40K | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 732 780 4400 | |||
| Address | 4400 Route 9 South Freehold, NJ 07728 | |||
| Website | www.avalon-globocare.com | |||
| Country | United States | |||
| Year Founded | 2016 | |||
| Profitability | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 165.14% | |||
| Profit Margin | 187.98% | |||
| Management Effectiveness | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -32.67% | |||
| Return on Equity | -- | |||
| Income Statement | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.31M | |||
| Total Revenue (TTM) | -7.84M | |||
| Revenue Per Share | -$8.48 | |||
| Gross Profit (TTM) | -8.87M | |||
| EBITDA (TTM) | -12.77M | |||
| EBIT (TTM) | -12.94M | |||
| Net Income (TTM) | -14.73M | |||
| Net Income Avl. to Common (TTM) | -14.73M | |||
| Total Revenue Growth (Q YOY) | -114.99% | |||
| Earnings Growth (Q YOY) | -13.07% | |||
| EPS Diluted (TTM) | -19.56 | |||
| EPS Diluted Growth (Q YOY) | 11.97% | |||
| Balance Sheet | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.02M | |||
| Cash Per Share (Q) | $1.11 | |||
| Total Current Assets (Q) | 1.40M | |||
| Total Preferred Equity (Q) | 20.00 | |||
| Total Equity (Q) | 5.40M | |||
| Current Ratio (Q) | 0.113 | |||
| Book Value Per Share (Q) | -$13.34 | |||
| Total Assets (Q) | 19.55M | |||
| Total Current Liabilities (Q) | 12.33M | |||
| Total Debt (Q) | 8.72M | |||
| Total Liabilities (Q) | 14.15M | |||
| Total Common Equity (Q) | -14.60M | |||
| Cash Flow | ALBT - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -100.00K | |||
| Cash from Financing (TTM) | 5.46M | |||
| Net Change in Cash (TTM) | 682.40K | |||
| Levered Free Cash Flow (TTM) | -7.13M | |||
| Cash from Operations (TTM) | -4.69M | |||
